In recent years, antimicrobial resistance (AMR) has become one of the greatest threats to human health. There is an urgent need to develop new antibacterial agents to effectively treat AMR infection. Herein, a novel nanozyme platform (Cu,N‐GQDs@Ru‐NO) is prepared, where Cu,N‐doped graphene quantum dots (Cu,N‐GQDs) are covalently functionalized with a nitric oxide (NO) donor, ruthenium nitrosyl (Ru‐NO). Under 808 nm near‐infrared (NIR) light irradiation, Cu,N‐GQDs@Ru‐NO demonstrates nicotinamide adenine dinucleotide (NADH) dehydrogenase‐like activity for photo‐oxidizing NADH to NAD+, thus disrupting the redox balance in bacterial cells and resulting in bacterial death; meanwhile, the onsite NIR light‐delivered NO effectively eradicates the methicillin‐resistant Staphylococcus aureus (MRSA) bacterial and biofilms, and promotes wound healing; furthermore, the nanozyme shows excellent photothermal effect that enhances the antibacterial efficacy as well. With the combination of NADH dehydrogenase activity, photothermal therapy, and NO gas therapy, the Cu,N‐GQDs@Ru‐NO nanozyme displays both in vitro and in vivo excellent efficacy for MRSA infection and biofilm eradication, which provides a new therapeutic modality for effectively treating MRSA inflammatory wounds.